Dr. Michael Wolf will serve as the site-PI at Northwestern. Dr. Wolf will oversee all study activities at the Northwestern performance site, and coordinate/supervise affiliated key personnel. In collaboration with Drs. Federman and Wisnivesky, Dr. Wolf will provide research, measurement, and project management expertise aiding in the study design and implementation, statistical analysis and interpretation. He will lead and co-author publication, as well as travel 1-2 times per year to New York for team meetings and co-facilitate bi-weekly calls. As a performance site, Northwestern will recruit 200 patients with COPD, and follow patients every 5 months for 15 months.
|Effective start/end date||6/1/18 → 5/31/19|
- Icahn School of Medicine at Mount Sinai (0255-8785-4609//5R01HL126508-05)
- National Heart, Lung, and Blood Institute (0255-8785-4609//5R01HL126508-05)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.